Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control 
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight 
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem 
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership 3M and Svante Announce Joint Development Agreement to Develop and Produce CO2 Removal Products
3M and Svante will partner to develop Direct Air Capture (DAC) products for the carbon…
AZIO Launches Tera 75 Keyboard, a Mechanical Keyboard With Interchangeable Design Materials – Now Live on Kickstarter
LOS ANGELES, CA, May 17, 2023 – (ACN Newswire) – The Tera 75 is AZIO’s…
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
PARIS, FRANCE, May 17, 2023 – (ACN Newswire) – AI Biotech Owkin, a leading provider…
tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat
KIEL, GERMANY, May 17, 2023 – (ACN Newswire) – tiakis Biotech AG (tiakis), in collaboration…
Tesla Veteran Appointed as Senior Vice President of Car Subscription Company, Autonomy
SANTA MONICA, Calif.,–(BUSINESS WIRE)–Autonomy™, the nation’s largest electric vehicle subscription company, announced that auto finance…
PepsiCo among Leading Brands Confronting Economic Headwinds with Customer Loyalty Innovations
Veryfi Lens fuels global loyalty campaigns with instant purchase validation and cross-basket insights SAN MATEO,…
Epicor Puts AI-Enabled Insights to Work for the Make, Move, and Sell Economy
LAS VEGAS–(BUSINESS WIRE)–Epicor, a global leader of industry-specific enterprise software to promote business growth, will…
Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice…
Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice…
IBT resolves on a rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
IBT resolves on a rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose Combination of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis (PBC)
Company on track to complete planned interim analyses from two ongoing Phase 2 studies of…
Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose Combination of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis (PBC)
Company on track to complete planned interim analyses from two ongoing Phase 2 studies of…
Editas Medicine Announces Appointment of Erick J. Lucera as Chief Financial Officer
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
Editas Medicine Announces Appointment of Erick J. Lucera as Chief Financial Officer
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
Bioventus Reports First Quarter Financial Results
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
Bioventus Reports First Quarter Financial Results
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
BioVie Presents Rationale for Potentially Pivotal Trial of NE3107 in the Treatment of Parkinson’s Disease at 2023 International Association of Parkinsonism and Related Disorders World Congress
CARSON CITY, Nev., May 16, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…